Skip Navigation LinksDDAP > Announcements


   You are viewing a page that contains frequently added announcements.  Subscribe to our RSS feed to receive announcements as they become available. 
10/10/2017 4:02 PM

This is a free family workshop coming up on October 14 sponsored by Bridge To Hope and Passavant Hospital Foundation.  Below are links to information on the seminar:

Details, agenda and presenters can be accessed at this link:  10.14.17 SUD Family Workshop<>
Pre-registration (with name and email address of each person attending) is requested by October 11 to (412) 748-5120 or<>.
9/22/2017 1:28 PM

A new instance of PA WITS will be implemented on 9/25/2017.  You may notice several new fields on screens while entering TEDS data.  Please be advised that none of these fields are mandatory at this time.  Please contact the PA WITS service desk with system related issues emailing or calling 571-252-5514.
8/30/2017 2:25 PM

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is currently in the process of submitting its FFY 2018-2019 Substance Abuse Block Grant Behavioral Health Plan, due October 1, 2017.  The Behavioral Health Plan is the portion of the federal block grant application that identifies DDAP’s assessment and plan for implementing and meeting block grant requirements.    The SAPT Block Grant Application is available on WebBGAS (  To access the application assessment and plan, log in as "citizenpa" and use "citizen" as your password.  Comments can be made at:

8/16/2017 2:43 PM

See attachment for information released regarding the kick-off event for National Recovery Month.

8/16/2017 12:10 PM

The position of the American College of Medical Toxicology (ACMT) and American Academy of Clinical Toxicology (AACT), is as follows: Fentanyl and its analogs are potent opioid receptor agonists, but the risk of clinically significant exposure to emergency responders is extremely low. To date, we have not seen reports of emergency responders developing signs or symptoms consistent with opioid toxicity from incidental contact with opioids.

You can access the ACMT and AACT Position Statement and full article at:
7/26/2017 12:49 PM

Please see attached Policy Bulletin 17-02​.

7/7/2017 1:47 PM

The June edition of The Phoenix newsletter is now available online.

6/26/2017 8:44 AM

Please find Fentanyl/Carfentanil resources, first responder information and fact sheets  in the links provided.





6/19/2017 9:51 AM

​See attached for Policy Bulletin 17-01

6/19/2017 9:45 AM

The PA Department of Drug and Alcohol Programs is re-issuing a Medical Assistance Application Guide which can be found at the following link:  This guide will assist providers and individuals in applying for Medical Assistance.

5/31/2017 3:01 PM

DDAP announces the release of a new monthly newsletter: The Phoenix Newsletter – 1st Edition. 

Please read it and send your feedback. We’d also like to include your stories. Please send both to Carol Gifford, editor, at  
Thank you.
5/22/2017 3:49 PM

Today the Department of Drug and Alcohol Programs (DDAP) announced the official go-live for the new DDAP Data System (PA WITS).
You can stream / download today’s webcast using the links below:
Additional information on PA WITS including: Training,  policy bulletin and the Business Associated-Qualified Service Organization Agreement (a.k.a. BAQSOA or QSOA) providers must enter into with FEi can be found at
Signed BAQSOAs should be returned to FEi, Inc at:
        Fax:  410-715-6538
Once FEi receives the agreement, they will activate all of the users for that agency based on the list of user accounts the provider compiled for DDAP several months ago.  Users will get an automated email to set up their account. 
Thank you.
5/22/2017 8:54 AM

Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT) today launched its free 24-hour course specifically developed for nurse practitioners (NPs) and physician assistants (PAs) to treat opioid use disorder (OUD).
PCSS-MAT is jointly providing the course with continuing education by the American Psychiatric Nurses Association (APNA) and American Academy of PAs (AAPA). 
The 24 hours of coursework, mandated by the Comprehensive Addiction and Recovery Act (CARA), is broken up into
1.   an eight-hour MAT waiver training and 
2.   16 hours of training for treating OUD 
Once the 24 hours of training are completed, NPs and PAs may apply to SAMHSA for a waiver to prescribe buprenorphine, one of three FDA-approved medications for the treatment of OUD.

Download instructions and information. 

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This program has been reviewed and is approved for a maximum of 8.00 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of 05/17/2017.
This program has been reviewed and is approved for a maximum of 16.00 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of 05/17/2017.
5/17/2017 12:58 PM

The Department of Drug and Alcohol Programs (DDAP) is excited to announce the official go-live for the new DDAP Data System (PA WITS) on May 22, 2017.  This version of the PA WITS system is being implemented two-months ahead of schedule for the purposes of collecting TEDS data since September 1, 2015.
We invite you to join a live streaming webcast to kick-off the first day of your access to PA WITS.  The webcast will be presented by DDAP project leaders covering important topics including:  policy requirements, e-Training, and how to gain access.  The webcast will be recorded and available for viewing at a later date.
View the webcast at this link on May 22nd at 11 AM: 
4/26/2017 11:21 AM

A PA Advisory Council on Drug and Alcohol Abuse subcommittee is compiling information on the availability of free grief support groups statewide that are specifically tailored for parents, siblings, spouses, etc. that have lost a loved one to addiction. If you are aware of any such groups, please send the information to Council member Jennifer Zampogna at  

4/14/2017 9:58 AM

The Centers for Medicare and Medicaid Services (CMS) is hosting a webinar entitled “Introduction to the American Society of Addiction Medicine (ASAM) Criteria for Clinical and Program Standards.” The webinar will provide an overview of the substance use disorder treatment care continuum and standards described in the American Society of Addiction Medicine (ASAM) Criteria. The webinar will provide an overview of all the ASAM Criteria levels of care, and then focus specifically on complex levels of care, including withdrawal management, early intervention, partial hospitalization, and clinically managed low-intensity residential services. The webinar will be held on Wednesday, April 19th from 3:30pm– 5:00pm EST. 
Register for the webinar here.
4/12/2017 8:19 AM

In preparing for the statewide transition from the Pennsylvania Client Placement Criteria (PCPC) to the American Society of Addiction Medicine (ASAM) Criteria, DDAP has prepared the attached list of Frequently Asked Questions which is also available on its website at the following location: .  Additional questions that are not currently addressed by the FAQ can be submitted to and updates will be made to the website on a regular basis.
4/6/2017 2:43 PM

The new toolkit of fliers, posters, brochures, Web ads, and other materials that are typically made available to help advertise the DEA’s National Prescription Drug Take-Back Day is now live at  The material is under the “Partnership Toolbox” button on the right-hand side.

Please feel free to pass this info along to your partnering organizations in drug abuse prevention so they can use these toolkit items, push them out to others, and help spread the word about the upcoming take-back day on April 29.
3/22/2017 10:43 AM

​Commonwealth Prevention Alliance Conference Registration NOW OPEN!!
The 27th Annual Commonwealth Prevention Alliance “Leading the Challenge” Prevention Conference brochure is now available to download, view and print from the CPA website.  Please view the brochure for detailed information prior to going to the online registration site.  Payments may be made by credit card or check.
The Pennsylvania Commission on Crime and Delinquency is once again offering up to 50 scholarships to this year’s conference.  The scholarship application process will only be open from March 20th through April 15th at 11:59 p.m.  Applicants for this need-based scholarship will be notified no later than May 12 of the result.  No one already registered for this year’s conference is eligible to apply.  For more detailed information on all eligibility requirements, please check the CPA website. 

Also available on the CPA website are the following:
•         Nomination forms for the Maggie Marcopul Award for Service to the Prevention Field Award.  Deadline: April 14th
•         Applications for the PA Coalition of the Year Award.   Intent to Apply Deadline: April 19, Application Deadline: May 12th
•         Application information for youth groups to apply for the Youth Conference and Rally.  Deadline: April 20th

And finally, it is now easier to apply for CPA membership through the new online membership registration program.  CPA members receive a significant discount on this year’s conference.  Membership payments can be made online with most major credit cards or by mailing in your check.  Check out the Membership page on CPA’s website for more details.  A listing of current members may be viewed there.
CPA Website Address:

3/16/2017 7:16 AM
​DDAP has, in consultation with the Governor’s Policy Office and the Office of General Counsel, weighed our options for continuing the use of our PCPC (Pennsylvania Client Placement Criteria) tool for determining the appropriate level of care for an individual seeking treatment or already within our treatment system.  After weighing the options, we have decided that the benefits of using a customized tool no longer exceed the benefits of using the nationally recognized ASAM (American Society of Addiction Medicine) tool.  One reason for the transition stems from the Centers for Medicare & Medicaid Services (CMS) Medicaid Managed Care Final Rule that was issued last summer, which will limit federal reimbursement for residential treatment of Medicaid recipients to 15 days.  In response to that rule, and specifically the provision related to the IMD exclusion, Pennsylvania aims to better position ourselves in submitting a 1115 waiver to CMS related to the IMD exclusion.  The 1115 waiver application requires the use of the ASAM tool.  This issue surrounding the IMD exclusion is not the only reason for making the change, however. The newly acquired treatment data system is already equipped with the ASAM continuum of care which will make this new system more usable with fewer modifications, which limits the risk of future system maintenance issues.  Additionally, because the ASAM is currently utilized for placement decisions related to adolescents, and by many commercial insurance providers for both adults as well as adolescents, converting to this tool will create consistency for providers and payers across the treatment system.
While there are multiple advantages to this conversion, we understand that it will not come without its challenges.  We have a team of employees who are currently in the process of establishing a strategic plan for transitioning from the PCPC to the ASAM and will be gathering input from stakeholders and establish a workable process that moves us to the use of the ASAM over time, with the goal of full implementation occurring by July 2018.  I will continue to keep you posted on the progress and impacts of this effort.  I would ask that this become a standing agenda item in our meetings with your membership.
1/18/2017 10:19 AM

Please find a link to the PA Department of Health’s Hepatitis C webpage which includes the PA Hepatitis C Epidemiologic Profile 2003-2014.


Hepatitis C Epidemiologic Profile in Pennsylvania


12/22/2016 9:44 AM

​The Pennsylvania Department of Drug and Alcohol Programs’ FY 2017 Annual Synar Report is currently available for review on the agency’s website: .  This report is submitted to SAMHSA as a requirement of the Substance Abuse Block Grant and provides information about initiatives aimed at decreasing youth access to tobacco. 

In addition to the DDAP website, this report along with the full SAPT Block Grant Application, is available on WebBGAS.  To access the block grant reports, log in as "citizenpa" and use "citizen" as your password.  Comments can be made at:

10/26/2016 3:30 PM



The Department of Drug and Alcohol Programs is pleased to announce that it is making available free, downloadable educational curricula to prevention providers and educators for the purpose of teaching digital and media literacy to middle and high-school students.
The “Media Straight Up! Critical Thinking Skills for Pennsylvania’s Youth” (middle school level) and “Pushing Back: Responding to Representation of Drugs and Alcohol in Popular Culture” (high school level) are curricula that provide specific instructional strategies for raising young people’s awareness and critical thinking skills in responding to mass and social media messages that depict alcohol, tobacco, prescription and illegal drug use. Digital and media literacy skills help students to evaluate the quality and accuracy of what they see, hear and read. They help them recognize how and why media messages appeal to their audience, sharpening awareness of unstated but implied messages. 
These media literacy curricula are a resource for any prevention specialist or educator to teach youth about the important skills of digital and media literacy which can contribute to a young person’s ability to understand how media messages affect their perceptions of drugs and alcohol, and may influence the choices they make. Prevention specialists, teachers, school counselors, and community leaders can each play a role in promoting critical thinking to our students about the unhealthy messages they hear and see daily throughout today’s media.
To download and/or learn more about these valuable and free resources, please visit:
8/22/2016 10:47 AM

​The Pennsylvania Gaming Control Board has launched a multi-faceted public service campaign to warn youth and parents about the dangers of attempting to gamble at a PA casino when underage.  Feel free to disseminate this information on your website, social media sites, etc. 

The campaign is titled “What’s Really at Stake” and is designed to raise awareness among youth that it is illegal to gain access to a casino floor in Pennsylvania under the age of 21, convey the numerous consequences of underage gambling, and demonstrate the link between underage gambling and other negative behaviors.
Additionally, the campaign provides messages to parents and friends who all too often facilitate gambling by an underager.
The campaign elements for disseminating its message include:
• A website,
• Social media posts on Facebook ( and Twitter (www.twitter/WhatsAtStakePA)
• YouTube Videos (
• Posters within PA casinos
All funding for the What’s Really at Stake campaign is derived from confiscated winnings of voluntary or involuntary excluded patrons who illegally entered a Pennsylvania casino, gained winnings, and were caught in the facility.
8/5/2016 1:21 PM

The Department of Drug and Alcohol Programs (DDAP) has released an innovative tool to identify available treatment beds for individuals in residential treatment programs.  For more information or to register, you can visit the PA Open Beds page on our website  or email  or call Dan Miller at 717-736-7466

8/5/2016 1:20 PM

DDAP wishes to make our stakeholders and the general public aware of two discount opportunities for the individual purchase of naloxone with a prescription or through the use of the Pennsylvania Physician General’s Standing Order:
•    Kaleo, the manufacturer of the “Evzio” naloxone auto-injector has announced that they will minimize the out-of-pocket cost to patients and their family members and caregivers by providing commercially-insured patients filing a prescription for EVZIO with an out-of-pocket cost of less than $20 or, in most cases, $0, even if their commercial insurance plan does not cover EVZIO.  This reduced price is through a pharmacy discount.  Additional information about this reduced price can be found at:
•   AdaptPharma, the manufacturer of Narcan Nasal Spray, has partnered with CVS Pharmacy to offer individuals without insurance a $35 discount coupon available through the local CVS pharmacy.
DDAP requests that this information be shared at large so that individuals are made aware of these opportunities for obtaining naloxone at a reduced cost.
(Note:  DDAP requests that pharmaceutical companies or pharmacy discount programs notify the Department of any additional price discounts as they become available so that they can be added to this announcement.)
8/4/2016 2:42 PM

The Department of Drug and Alcohol Programs (DDAP) is concerned about the rise in hepatitis C cases in Pennsylvania (PA), particularly among persons who inject drugs (IDU).  The Centers for Disease Control and Prevention recommends hepatitis C virus (HCV) testing for those who currently inject any type of drug (Opioids, Methamphetamine, Cocaine, etc.) or have injected drugs in the past, including those who injected once or a few times many years ago.  PA has experienced a dramatic increase in hepatitis C infections in individuals with injection opioid and/or heroin addiction who are 18 to 35 years of age.  DDAP recommends that all licensed drug and alcohol addiction treatment facilities perform a risk assessment for HCV and refer to medical or community based providers for necessary screening/testing as appropriate.
Because many individuals you serve are at high risk for hepatitis C, you play an important role in combating this public health issue.  If you have current practices that you believe are effective in combating this disease, we would appreciate you sharing these with us so we can promote them across the field.  Please send this information to Justin White at
Through improved identification and treatment of individuals with hepatitis C, we can begin to reduce the spread of this disease.  Please remember to obtain consumer consent and maintain confidentiality when sharing test results with the consumers’ primary care physicians or other physical health specialists involved in hepatitis treatment.  In some cases, you may be able to utilize a Qualified Service Organization Agreement (QSOA) to permit the exchange of patient identifying information.  If you have questions about when this is possible, please contact our Division of Licensing Director, Treldon Johnson, at
For more information regarding hepatitis C testing of IDU clientele, please contact:
Charles Howsare, MD, MPH
Viral Hepatitis Prevention Coordinator
PA Department of Health
Thank you for your critical assistance in controlling hepatitis C in PA.
Contact Person:  Justin White
6/22/2016 7:42 AM

​​DDAP is currently working with Department of Human Services, Division of Facilities and Property Management to identify locations in the Commonwealth that our Drug and Alcohol provider network might be able to  leverage for expansion of services.  These locations may be more affordable and require less effort than building a new facility. Current list of available locations is attached. If a provider is interested in seeing the properties available, or would like more information regarding this,  please contact Jodi Skiles at or 717-736-7454.

6/22/2016 7:38 AM

​Please be aware of the following communication/commitment from Kaleo Pharmaceutical for individual persons obtaining naloxone via their pharmacy:

Any commercially insured person with a prescription can now quickly obtain EVZIO with an out-of-pocket cost of, in most cases, $0, even if their insurance does not cover EVZIO. To facilitate this, Kaleo Pharmaceutical has a toll free number, 877-4-EVZIO-EZ, that patients, physicians, or pharmacists can use to get immediate assistance to fill this potentially life-saving prescription.

Feel free to share this information with others.

6/22/2016 7:37 AM

​DDAP and the PA Department of Health have been working closely with the PA Medical Society (PAMED) to support their efforts to create a free Continuing Medical Education (CME) related to “Addressing Pennsylvania's Opioid Crisis: What the Health Care Team Needs to Know.”   This CME program is divided into four modules and covers a variety of tools and resources for prescribers and dispensers to better address opioid addiction. 

  1. Opioid Prescribing Guidelines
  2. Naloxone Prescribing
  3. Referral to Treatment   
  4. In process: Prescription Drug Monitoring Program called the ACHIEVING BETTER CARE BY MONITORING ALL PRESCRIPTIONS PROGRAM or (ABC-MAP) 

PAMED has decided to make ALL their opioid CME’s available at no-cost until the end of the 2016 calendar year.  Given the extent of the opioid crisis and the urgent need for physicians and other providers to get up to speed on opioid prescribing guidelines, naloxone, referrals to treatment, and the ABC-MAP Program, PAMED wanted to promote this CME to ALL members of the healthcare team that need it.  With that in mind, your group may want to consider doing the same if you are currently charging for the series.  The link to PAMED’s CME that is includes the test and certificate for CME credits is:

Also, PAMED is going to be developing a 5th module on “Alternative Treatment of Pain” that will highlight non-opioid medication, OT/PT, complementary medicine, and behavior health approaches to managing chronic, non-cancer pain. 

1 - 30Next